help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honda, Y.
Right arrow Articles by Abe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honda, Y.
Right arrow Articles by Abe, S.

Am. J. Respir. Crit. Care Med., Vol 152, No. 6, Dec 1995, 1860-1866.

Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids

Y Honda, Y Kuroki, E Matsuura, H Nagae, H Takahashi, T Akino and S Abe
Third Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.

Pulmonary surfactant protein D (SP-D) is a hydrophilic glycoprotein with a reduced molecular mass of 43 kDa and a member of the C-type lectin superfamily, along with mannose-binding proteins and surfactant protein A (SP-A). We have recently prepared monoclonal antibodies against human SP-D and developed an enzyme-linked immunosorbent assay (ELISA). In this study, the levels of SP-D in sera and bronchoalveolar lavage (BAL) fluids of patients with lung diseases were determined by ELISA, using human recombinant SP-D as a standard. We demonstrated that the concentrations of SP-D in sera are prominently increased in patients with idiopathic pulmonary fibrosis (IPF), interstitial pneumonia with collagen disease (IPCD), and pulmonary alveolar proteinosis (PAP). Patients with IPF, IPCD, and PAP exhibited levels of serum SP-D 5.1-fold, 7.2-fold, and 7.0-fold, respectively, of those in healthy volunteers; 91.5% of the patients with IPF, 81.3% with IPCD, and 100% with PAP exhibited serum SP-D levels that exceeded the cut-off value (mean + 2 SD of control value). Serum SP-D levels appeared to reflect the disease activity of IPF and IPCD and the disease severity of PAP. High levels of SP-D in BAL fluids were shown in patients with PAP, but not with IPF and IPCD. We conclude that measurement of SP-D in sera can provide an easily identifiable and useful clinical marker for the diagnosis of IPF, IPCD, and PAP, and can predict the disease activity of IPF and IPCD and the disease severity of PAP.


This article has been cited by other articles:


Home page
ChestHome page
E. Miyazaki, S.-i. Nureki, E. Ono, M. Ando, O. Matsuno, T. Fukami, T. Ueno, and T. Kumamoto
Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury
Chest, June 1, 2007; 131(6): 1726 - 1734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. L. Sorensen, J. v. B. Hjelmborg, K. O. Kyvik, M. Fenger, A. Hoj, C. Bendixen, T. I. A. Sorensen, and U. Holmskov
Genetic and environmental influences of surfactant protein D serum levels
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L1010 - L1017.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Kashiwabara
Characteristics and disease activity of early interstitial lung disease in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung.
Chest, February 1, 2006; 129(2): 402 - 406.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Higashi, N. Higashi, T. Tsuburai, Y. Takeuchi, M. Taniguchi, H. Mita, A. Saito, K. Takatori, K. Arimura, and K. Akiyama
Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis
Eur. Respir. J., December 1, 2005; 26(6): 1069 - 1073.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Q. A. Al-Salmi, J. N. Walter, G. N. Colasurdo, M. M. Sockrider, E. O. Smith, H. Takahashi, and L. L. Fan
Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease
Chest, January 1, 2005; 127(1): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Janssen, H. Sato, J. C. Grutters, A. Bernard, H. van Velzen-Blad, R. M. du Bois, and J. M. M. van den Bosch
Study of Clara Cell 16, KL-6, and Surfactant Protein-D in Serum as Disease Markers in Pulmonary Sarcoidosis
Chest, December 1, 2003; 124(6): 2119 - 2125.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nadesalingam, A. L. Bernal, A. W. Dodds, A. C. Willis, D. J. Mahoney, A. J. Day, K. B. M. Reid, and N. Palaniyar
Identification and Characterization of a Novel Interaction between Pulmonary Surfactant Protein D and Decorin
J. Biol. Chem., July 3, 2003; 278(28): 25678 - 25687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. G. De Pasquale, A. D. Bersten, I. R. Doyle, P. E. Aylward, and L. F. Arnolda
Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2136 - H2145.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J F Seymour, I R Doyle, K Nakata, J J Presneill, O D Schoch, E Hamano, K Uchida, R Fisher, and A R Dunn
Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis
Thorax, March 1, 2003; 58(3): 252 - 257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Bufler, B. Schmidt, D. Schikor, A. Bauernfeind, E. C. Crouch, and M. Griese
Surfactant Protein A and D Differently Regulate the Immune Response to Nonmucoid Pseudomonas aeruginosa and Its Lipopolysaccharide
Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H Ishii, H Mukae, J Kadota, H Kaida, T Nagata, K Abe, S Matsukura, and S Kohno
High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia
Thorax, January 1, 2003; 58(1): 52 - 57.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. K. Sarady, S. L. Otterbein, F. Liu, L. E. Otterbein, and A. M. K. Choi
Carbon Monoxide Modulates Endotoxin-Induced Production of Granulocyte Macrophage Colony-Stimulating Factor in Macrophages
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Ihn, Y. Asano, M. Kubo, K. Yamane, M. Jinnin, N. Yazawa, M. Fujimoto, and K. Tamaki
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease
Rheumatology, November 1, 2002; 41(11): 1268 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chiba, S. Pattanajitvilai, A. J. Evans, R. J. Harbeck, and D. R. Voelker
Human Surfactant Protein D (SP-D) Binds Mycoplasma pneumoniae by High Affinity Interactions with Lipids
J. Biol. Chem., May 31, 2002; 277(23): 20379 - 20385.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K.E. Greene, T.E. King Jr, Y. Kuroki, B. Bucher-Bartelson, G.W. Hunninghake, L.S. Newman, H. Nagae, and R.J. Mason
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis
Eur. Respir. J., March 1, 2002; 19(3): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. OHNISHI, A. YOKOYAMA, K. KONDO, H. HAMADA, M. ABE, K. NISHIMURA, K. HIWADA, and N. KOHNO
Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 378 - 381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. F. Herbein and J. R. Wright
Enhanced clearance of surfactant protein D during LPS-induced acute inflammation in rat lung
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L268 - L277.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Takahashi, Y. Imai, T. Fujishima, M. Shiratori, S. Murakami, H. Chiba, H. Kon, Y. Kuroki, and S. Abe
Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis
Eur. Respir. J., March 1, 2001; 17(3): 481 - 487.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Tanaka, H. Sugawara, T. Saikai, K. Tsunematsu, H. Takahashi, and S. Abe
Mushroom Worker's Lung Caused by Spores of Hypsizigus marmoreus (Bunashimeji) : Elevated Serum Surfactant Protein D Levels
Chest, November 1, 2000; 118(5): 1506 - 1509.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. TAKAHASHI, T. FUJISHIMA, H. KOBA, S. MURAKAMI, K. KUROKAWA, Y. SHIBUYA, M. SHIRATORI, Y. KUROKI, and S. ABE
Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1109 - 1114.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. TAKAHASHI, Y. KUROKI, H. TANAKA, T. SAITO, K. KUROKAWA, H. CHIBA, A. SAGAWA, H. NAGAE, and S. ABE
Serum Levels of Surfactant Proteins A and D Are Useful Biomarkers for Interstitial Lung Disease in Patients with Progressive Systemic Sclerosis
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 258 - 263.
[Abstract] [Full Text]


Home page
ThoraxHome page
Z. Yang, S. M Jaeckisch, and C. G Mitchell
Enhanced binding of Aspergillus fumigatus spores to A549 epithelial cells and extracellular matrix proteins by a component from the spore surface and inhibition by rat lung lavage fluid
Thorax, July 1, 2000; 55(7): 579 - 584.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. S. CARRAWAY, A. J. GHIO, J. D. CARTER, and C. A. PIANTADOSI
Detection of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Pulmonary Alveolar Proteinosis
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1294 - 1299.
[Abstract] [Full Text]


Home page
ThoraxHome page
P. L Shah, D. Hansell, P. R Lawson, K. B M Reid, and C. Morgan
Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis
Thorax, January 1, 2000; 55(1): 67 - 77.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. E. GREENE, J. R. WRIGHT, K. P. STEINBERG, J. T. RUZINSKI, E. CALDWELL, W. B. WONG, W. HULL, J. A. WHITSETT, T. AKINO, Y. KUROKI, et al.
Serial Changes in Surfactant-associated Proteins in Lung and Serum before and after Onset of ARDS
Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1843 - 1850.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. S. Ferguson, D. R. Voelker, F. X. McCormack, and L. S. Schlesinger
Surfactant Protein D Binds to Mycobacterium tuberculosis Bacilli and Lipoarabinomannan via Carbohydrate-Lectin Interactions Resulting in Reduced Phagocytosis of the Bacteria by Macrophages1
J. Immunol., July 1, 1999; 163(1): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. O. Aderibigbe, R. F. Thomas, R. R. Mercer, and R. L. Auten Jr.
Brief Exposure to 95% Oxygen Alters Surfactant Protein D and mRNA in Adult Rat Alveolar and Bronchiolar Epithelium
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 219 - 227.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. HERMANS and A. BERNARD
Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers
Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678.
[Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. J. Tino and J. R. Wright
Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages
Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L164 - L174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. YOKOYAMA, N. KOHNO, H. HAMADA, M. SAKATANI, E. UEDA, K. KONDO, Y. HIRASAWA, and K. HIWADA
Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1680 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. J. Mason, K. Greene, and D. R. Voelker
Surfactant protein A and surfactant protein D in health and disease
Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L1 - L13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. L. Hartshorn, E. Crouch, M. R. White, M. L. Colamussi, A. Kakkanatt, B. Tauber, V. Shepherd, and K. N. Sastry
Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria
Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L958 - L969.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. R. DOYLE, A. D. BERSTEN, and T. E. NICHOLAS
Surfactant Proteins-A and -B Are Elevated in Plasma of Patients with Acute Respiratory Failure
Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1217 - 1229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society